Biostage (BSTG) Tops Q3 EPS by 7c

Biostage (NASDAQ: BSTG) reported Q3 EPS of ($0.18), $0.07 better than the analyst estimate of ($0.25). Revenue for the quarter came in at $26 million versus the consensus estimate of $30 thousand.

For earnings history and earnings-related data on Biostage (BSTG) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• Rein Therapeutics Inc. (RNTX) Tops Q2 EPS by 39c
• Zeo Energy Corp (ZEO) Misses Q2 EPS by 7c